Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Pulse Biosciences (PLSE) Other Gross PP&E Adjustments (2020 - 2025)

Pulse Biosciences has reported Other Gross PP&E Adjustments over the past 6 years, most recently at -$2.7 million for Q3 2025.

  • Quarterly results put Other Gross PP&E Adjustments at -$2.7 million for Q3 2025, up 8.21% from a year ago — trailing twelve months through Sep 2025 was -$2.7 million (up 8.21% YoY), and the annual figure for FY2024 was -$2.4 million, up 41.35%.
  • Other Gross PP&E Adjustments for Q3 2025 was -$2.7 million at Pulse Biosciences, up from -$3.2 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for PLSE hit a ceiling of -$2.4 million in Q4 2024 and a floor of -$5.3 million in Q1 2021.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$3.8 million (2025), compared with a mean of -$3.8 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: crashed 303.34% in 2021 and later surged 41.35% in 2024.
  • Pulse Biosciences' Other Gross PP&E Adjustments stood at -$4.0 million in 2021, then decreased by 22.59% to -$5.0 million in 2022, then rose by 17.3% to -$4.1 million in 2023, then surged by 41.35% to -$2.4 million in 2024, then decreased by 11.69% to -$2.7 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were -$2.7 million (Q3 2025), -$3.2 million (Q2 2025), and -$3.8 million (Q1 2025) per Business Quant data.